Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate: preliminary aggregate results from three phase 1a randomized, double-blind, placebo controlled clinical trials

Bibliographische Detailangaben

Veröffentlicht in:	The Lancet (British edition) 2017-12, Vol.391 (10120), p.563-571
Hauptverfasser:	Modjarrad, Kayvon, Lin, Leyi, George, Sarah L, Stephenson, Kathryn E, Eckels, Kenneth H, De La Barrera, Rafael A, Jarman, Richard G, Sondergaard, Erica, Tennant, Janice, Ansel, Jessica, Mills, Kristin, Koren, Michael, Robb, Merlin L, Barrett, Jill, Thompson, Jason, Kosel, Alison E, Dawson, Peter, Hale, Andrew, Tan, C Sabrina, Walsh, Stephen, Meyer, Keith E, Brien, James, Crowell, Trevor A, Blazevic, Azra, Mosby, Karla, Larocca, Rafael A, Abbink, Peter, Boyd, Michael, Bricault, Christine A, Seaman, Michael, Basil, Anne, Walsh, Melissa, Tonwe, Veronica, Hoft, Daniel F, Thomas, Stephen J, Barouch, Dan H, Michael, Nelson L
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!